Ethylene Oxide Sterilisation SWMS: ALARP Controls for an NTGC Sterilant
Ethylene oxide (EtO, oxirane) is the primary chemical sterilant used in Australian hospitals and medical device manufacturing for heat-sensitive instruments, single-use devices, and implantable products that cannot be processed by steam autoclave or dry heat. EtO is highly effective as a sterilant because it kills bacterial endospores, but the same reactivity that makes it lethal to microorganisms also makes it acutely toxic and genotoxically carcinogenic to humans. The International Agency for Research on Cancer (IARC) classifies ethylene oxide as a Group 1 carcinogen — a confirmed cause of lymphoma, leukaemia, and breast cancer in workers with occupational EtO exposure.
SWMS variants reference your state’s WHS legislation. Instant download after payment.
Legal Requirements
WHS Regulations 2017, Part 7.1 (Hazardous Chemicals), regulations 356–383 (Health monitoring); Workplace Exposure Standards for Airborne Contaminants (SWA, amended effective 1 December 2026): ethylene oxide reclassified as NTGC — ALARP obligation replaces numerical WEL (previously 1 ppm TWA / 5 ppm STEL)
Category 10 — Work involving hazardous material (WHS Regulation r291(1)(j)); ethylene oxide is a Schedule 10 hazardous chemical with mandatory health surveillance under r356; potentially Category 5 (confined space — steriliser chamber during unloading)
Model Code of Practice: Managing Risks of Hazardous Chemicals in the Workplace (SWA 2021); AS/NZS ISO 11135:2019 (EtO sterilisation); Dangerous Goods legislation (ethylene oxide UN 1040, Class 2.3 / Class 2.1); state EPA requirements for EtO atmospheric emissions
true
Hazards
| Hazard | Consequence | Likelihood |
|---|---|---|
| Inhalation of ethylene oxide gas during cylinder change, connection, and disconnection at the steriliser | EtO cylinder change is the highest single-event acute exposure task. | Almost Certain (A) during cylinder change without supplied-air RPE and positive-pressure engineering controls |
| Inhalation of ethylene oxide during chamber door opening after cycle completion | When the steriliser chamber door is opened at the end of a cycle, residual EtO that has not been fully removed by the aeration/evacuation cycle is released. | Likely (B) without continuous EtO air monitoring at the chamber door and mandatory RPE during door opening |
| Skin and eye contact with liquid ethylene oxide or high-concentration EtO gas condensate | Liquid EtO can cause severe chemical burns on skin and corneal damage on eye contact. | Possible (C) during cylinder handling, maintenance, or line breakage |
| Explosion and fire risk from ethylene oxide in the flammable range (3–100% by volume in air) | Ethylene oxide has an exceptionally wide flammable range — 3% to 100% by volume in air — meaning virtually any EtO–air mixture can ignite. | Unlikely (D) with correct engineering but consequences are catastrophic (E) |
| Chronic reproductive toxicity from ongoing EtO exposure in workers of reproductive age | Ethylene oxide is classified as a Category 1B reproductive toxin (known human reproductive toxicant). | Possible (C) with current WEL-based controls; risk persists even at exposures below the former numerical WEL |
| Atmospheric emissions of ethylene oxide from the steriliser exhaust and aeration cabinet, creating neighbourhood exposure risk | EtO sterilisers vent exhaust gas — including residual EtO — through the facility's exhaust system to the external atmosphere. | Likely (B) without an EtO catalytic converter or scrubber on the exhaust stack |
Controls (Hierarchy of Controls)
Recent Prosecutions
A metropolitan hospital's CSSD was found to have inadequate EtO air monitoring (annual sampling only), no biological monitoring programme, and relied on disposable half-face respirators (not supplied-air) during cylinder change. Two CSSD workers reported symptoms consistent with EtO overexposure — headache, nausea, and paraesthesia — following a cylinder change. WorkSafe issued prohibition and improvement notices, required immediate installation of continuous EtO monitoring, SAR procurement, and engagement of an occupational hygienist for a full exposure assessment. The hospital was required to commission haemoglobin adduct biological monitoring for all workers with EtO exposure history.
2023 — WorkSafe Victoria enforcement register
Following the December 2026 NTGC reclassification of ethylene oxide, state WHS regulators and health department safety branches announced targeted EtO sterilisation audits. Facilities without documented ALARP assessments, without continuous EtO air monitoring, and without biological monitoring programmes using haemoglobin adduct testing face Category 1 prosecution risk. The combination of NTGC status, reproductive toxin classification, and explosive hazard gives EtO the highest overall WHS risk profile of any chemical sterilant in clinical use.
2026 — Safe Work Australia NTGC Transition Guidance; state EPA enforcement registers
What Your SWMS Must Include
SWMS templates for this work
🧪Clinical Sterilisation SWMS
Central sterile services department (CSSD) reprocessing operations — manual pre-clean, ultrasonic and washer-d…
🏥Ethylene Oxide Sterilisation SWMS
Use, handling, and maintenance of ethylene oxide gas sterilisation equipment in CSSD departments, hospital ste…
🔥Aluminium Welding Fume SWMS
Aluminium MIG and TIG welding — aluminium oxide and ozone fume controls, ventilation, RPE selection for alumin…
EtO NTGC from 1 December 2026 — ALARP, Continuous Monitoring, Haemoglobin Adduct Testing Required
This template pre-loads EtO-specific hazards, the NTGC ALARP obligation, cylinder change and chamber opening controls, biological monitoring requirements (haemoglobin adduct), confined space considerations, and EPA compliance checkpoints. CIH-reviewed, editable DOCX, 8 Australian state variants. $79 AUD.
Get Ethylene Oxide Sterilisation SWMS — $79 →